Previous 10 | Next 10 |
LAKE FOREST, Ill., May 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that management will present at the 2019 RBC Capital Markets Healthcare Conference on Wednesday, May 22, 2019 at 2:05 p.m. EDT in New York...
If you have followed me on SeekingAlpha for the last few years, then you are well aware of the drama surrounding Akorn Pharmaceuticals ( AKRX ). Although the company has had a checkered past, I believe the company presents an intriguing opportunity for investors with a high level of risk tol...
Teva Pharmaceutical Industries (NYSE: TEVA ) slumps 8% premarket on light volume as investors react to its role in alleged price fixing by generic drug firms. Last night, the investigative journalism show 60 Minutes aired a piece on the issue that named the company as one of th...
Gainers: Attis Industries (NASDAQ: ATIS ) +49% . MACOM Technology Solutions Holdings (NASDAQ: MTSI ) +28% . Akorn (NASDAQ: AKRX ) +28% . Chanticleer Holdings (NASDAQ: BURG ) +26% . Corindus Vascular Robotics (NYSEMKT: CVRS ) +21% . Avalara (NYSE: AVLR ) +20% . Conformis (NASDAQ...
Akorn, Inc. (AKRX) Q1 2019 Earnings Conference Call May 07, 2019 10:00 AM ET Company Participants Jennifer Bowles - Senior Vice President and Corporate Strategy & Investor Relations Douglas Boothe - President & Chief Executive Officer Duane Portwood - Chief Financial Offi...
Gainers: Bridgeline Digital (NASDAQ: BLIN ) +30% . Cohu (NASDAQ: COHU ) +27% . ATA (NASDAQ: ATAI ) +25% . ARCA biopharma (NASDAQ: ABIO ) +24% . SolarEdge Technologies (NASDAQ: SEDG ) +23% . Summit Wireless Technologies (NASDAQ: WISA ) +22% . Itron (NASDAQ: ITRI ) +21% . Sunwor...
Bridgeline Digital (NASDAQ: BLIN ) +37% on announcing OrchestraCMS multi-year license renewal with global biopharmaceutical company. More news on: Bridgeline Digital, Inc., Akorn, Inc., Akoustis Technologies, Inc., Stocks on the move, Read more ...
Akorn ( AKRX ) Q1 results : Revenues: $165.9M (-9.9%). More news on: Akorn, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Akorn (NASDAQ: AKRX ): Q1 Non-GAAP EPS of -$0.10 beats by $0.07 ; GAAP EPS of -$0.65. More news on: Akorn, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
-Operational improvements drive sequential growth- -Full year outlook anticipates further sequential growth throughout the year- LAKE FOREST, Ill., May 07, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its...
News, Short Squeeze, Breakout and More Instantly...
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg PR Newswire GURNEE, Ill. , Aug. 16, 2022 /PRNewswire/ -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic v...
LAKE FOREST, Ill. , May 20, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company ("Akorn" or the "Company"), today announced that the Company and its U.S. subsidiaries filed for voluntary protection under Chapter 11 ("Chapter 11") of the U.S. Bankrup...
Are These On Your List Of Penny Stocks To Watch This Week? It can be tough at times to trade penny stocks . Some days there are only a few names to choose from. But there are other days where there seems to be plenty of penny stocks to buy . In either case, having your plan in place can defi...